Literature DB >> 32167574

The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecology.

Sathish Paramasivan1, Ahmed Bassiouni1, Arron Shiffer2, Matthew R Dillon2, Emily K Cope2, Clare Cooksley1, Mahnaz Ramezanpour1, Sophia Moraitis1, Mohammad Javed Ali3, Benjamin Bleier4, Claudio Callejas5, Marjolein E Cornet6, Richard G Douglas7, Daniel Dutra8, Christos Georgalas6, Richard J Harvey9,10, Peter H Hwang11, Amber U Luong12, Rodney J Schlosser13, Pongsakorn Tantilipikorn14, Marc A Tewfik15, Sarah Vreugde1, Peter-John Wormald1, J Gregory Caporaso2, Alkis J Psaltis1.   

Abstract

The sinonasal microbiome remains poorly defined, with our current knowledge based on a few cohort studies whose findings are inconsistent. Furthermore, the variability of the sinus microbiome across geographical divides remains unexplored. We characterize the sinonasal microbiome and its geographical variations in both health and disease using 16S rRNA gene sequencing of 410 individuals from across the world. Although the sinus microbial ecology is highly variable between individuals, we identify a core microbiome comprised of Corynebacterium, Staphylococcus, Streptococcus, Haemophilus and Moraxella species in both healthy and chronic rhinosinusitis (CRS) cohorts. Corynebacterium (mean relative abundance = 44.02%) and Staphylococcus (mean relative abundance = 27.34%) appear particularly dominant in the majority of patients sampled. Amongst patients suffering from CRS with nasal polyps, a statistically significant reduction in relative abundance of Corynebacterium (40.29% vs 50.43%; P = .02) was identified. Despite some measured differences in microbiome composition and diversity between some of the participating centres in our cohort, these differences would not alter the general pattern of core organisms described. Nevertheless, atypical or unusual organisms reported in short-read amplicon sequencing studies and that are not part of the core microbiome should be interpreted with caution. The delineation of the sinonasal microbiome and standardized methodology described within our study will enable further characterization and translational application of the sinus microbiota.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  16S rRNA gene; chronic rhinosinusitis; microbiome; next-generation sequencing; sinus

Mesh:

Substances:

Year:  2020        PMID: 32167574     DOI: 10.1111/all.14276

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

Review 1.  Unraveling the role of the microbiome in chronic rhinosinusitis.

Authors:  Alkis J Psaltis; Brett Wagner Mackenzie; Emily K Cope; Vijay R Ramakrishnan
Journal:  J Allergy Clin Immunol       Date:  2022-03-14       Impact factor: 14.290

Review 2.  Bacterial Community Interactions During Chronic Respiratory Disease.

Authors:  Allison L Welp; Jennifer M Bomberger
Journal:  Front Cell Infect Microbiol       Date:  2020-05-14       Impact factor: 5.293

3.  Microbiotyping the Sinonasal Microbiome.

Authors:  Ahmed Bassiouni; Sathish Paramasivan; Arron Shiffer; Matthew R Dillon; Emily K Cope; Clare Cooksley; Mahnaz Ramezanpour; Sophia Moraitis; Mohammad Javed Ali; Benjamin S Bleier; Claudio Callejas; Marjolein E Cornet; Richard G Douglas; Daniel Dutra; Christos Georgalas; Richard J Harvey; Peter H Hwang; Amber U Luong; Rodney J Schlosser; Pongsakorn Tantilipikorn; Marc A Tewfik; Sarah Vreugde; Peter-John Wormald; J Gregory Caporaso; Alkis J Psaltis
Journal:  Front Cell Infect Microbiol       Date:  2020-04-08       Impact factor: 5.293

4.  Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota.

Authors:  Christian A Lux; Brett Wagner Mackenzie; James Johnston; Melissa Zoing; Kristi Biswas; Michael W Taylor; Richard G Douglas
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

Review 5.  The Interplay between the Unfolded Protein Response, Inflammation and Infection in Cystic Fibrosis.

Authors:  Pascal Trouvé; Claude Férec; Emmanuelle Génin
Journal:  Cells       Date:  2021-11-02       Impact factor: 6.600

Review 6.  Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity.

Authors:  Gohar Shaghayegh; Clare Cooksley; Mahnaz Ramezanpour; Peter-John Wormald; Alkis James Psaltis; Sarah Vreugde
Journal:  Biomedicines       Date:  2022-06-09

7.  Preprocedural COVID-19 screening: Do rhinologic patients carry a unique risk burden for false-negative results?

Authors:  Benjamin S Bleier; Kevin C Welch
Journal:  Int Forum Allergy Rhinol       Date:  2020-07-15       Impact factor: 5.426

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.